PIN2K Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Context

The PIN1 Antibody (10495-1-AP) is a polyclonal rabbit antibody targeting the Peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1 (PIN1) protein. PIN1 is a mitotic regulator implicated in cancer progression and cellular differentiation . While the term "PIN2K" is not referenced in the provided sources, it may refer to a theoretical or emerging variant of PIN1 antibodies, which are not yet cataloged in mainstream databases.

Applications and Validation

The PIN1 Antibody (10495-1-AP) is validated for multiple techniques:

ApplicationDilutionTested Reactivity
Western Blot (WB)1:2000–1:10,000Human, mouse, rat
Immunoprecipitation (IP)0.5–4.0 µg/mg lysateHuman, mouse, rat
Immunohistochemistry (IHC)1:50–1:500Human renal carcinoma, pancreas cancer
Immunofluorescence (IF)1:50–1:500HEK-293, NIH/3T3 cells

Published Studies:

  • Cancer Research: PIN1 inhibition disrupts the tumor microenvironment (TME) and enhances PD-L1 expression in pancreatic ductal adenocarcinoma (PDAC), rendering tumors susceptible to immunochemotherapy .

  • Molecular Pathology: PIN1 antibodies are used to study its role in mitosis and differentiation, with colocalization observed with NEK6 in nuclear compartments .

Relevance in Broader Antibody Research

Antibodies like PIN1 (10495-1-AP) are critical for biomedical research, enabling protein identification and quantification . Their specificity is rigorously validated through initiatives like YCharOS, which has led to the removal of over 200 poorly performing commercial antibodies . This underscores the importance of high-quality reagents in advancing disease modeling, such as in antiphospholipid syndrome (APS) nephropathy, where Tyk2 inhibitors modulate immune responses .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PIN2KProteinase inhibitor type-2 K antibody; Proteinase inhibitor type II K antibody; IIK) [Cleaved into: Proteinase inhibitor PCI-1 antibody; Proteinase inhibitor PCI-I)] antibody
Target Names
PIN2K
Uniprot No.

Target Background

Function
PIN2K Antibody is an inhibitor of trypsin and chymotrypsin.
Database Links

UniGene: Stu.20756

Protein Families
Protease inhibitor I20 (potato type II proteinase inhibitor) family

Q&A

What is PIN2K and why is it significant in protease inhibitor research?

PIN2K (proteinase inhibitor type-2 K, I20.001) belongs to a family of serine protease inhibitors that plays crucial roles in regulating proteolytic cascades. It functions by forming stable complexes with target proteases, preventing substrate access to the active site.

PIN2K is particularly significant in research contexts because:

  • It exhibits high specificity for certain serine proteases

  • It has a conserved structure that makes it an excellent model for studying protease-inhibitor interactions

  • It can be expressed recombinantly in various host systems for research applications

For researchers studying PIN2K, careful consideration of expression systems is essential. As noted in recent studies, co-expression of proteinaceous inhibitors with their target proteases can optimize expression levels and functional activity .

How do I design effective experimental controls when studying PIN2K antibodies?

When designing experiments involving PIN2K antibodies, implement these methodological controls:

Control TypePurposeImplementation
Isotype controlControls for non-specific bindingUse same isotype antibody with irrelevant specificity
Blocking controlsValidate specificityPre-incubate antibody with purified PIN2K
Knockout/knockdownConfirm target validityUse PIN2K-deficient samples
Cross-reactivity assessmentDetermine specificityTest against related protease inhibitors (e.g., aprotinin)
Epitope mapping controlsConfirm binding siteTest against PIN2K fragments or mutants

When using multiple antibodies, carefully assess potential interference between binding sites. Recent studies with coronavirus antibodies demonstrate how pairs of antibodies can work cooperatively - one anchoring to a conserved region while the other targets functional domains .

What expression systems are recommended for generating PIN2K for antibody development?

When expressing PIN2K for antibody generation or characterization, several expression systems offer distinct advantages:

Pichia pastoris expression system:

  • Demonstrated high yield for proteinase inhibitors

  • Capable of proper folding and post-translational modifications

  • Can co-express the inhibitor with its target protease to improve yields

Mammalian expression systems:

  • More likely to produce correctly folded protein with native conformation

  • Essential when studying antibody binding to conformational epitopes

  • Enables production via transient or stable transfection methods

For optimal results, consider these methodological approaches:

  • Engineer codon-optimized sequences for your expression host

  • Include purification tags that can be removed without affecting protein structure

  • Consider co-expression strategies with chaperones or target proteases

  • Validate protein folding through functional assays before antibody development

What are the best strategies for developing high-specificity antibodies against PIN2K?

Developing highly specific antibodies against PIN2K requires strategic approaches:

Phage Display Method:
Human naïve antibody libraries containing >7×10¹⁰ individual clones provide an effective starting point for antibody discovery. This approach yields antibodies with high binding affinity (KD = 10⁻⁹-10⁻¹⁰ M) without animal immunization .

Affinity Maturation:
To enhance antibody specificity and affinity:

  • Create focused libraries through targeted mutagenesis of CDR regions

  • Perform stringent selection with increasing washing steps

  • Apply competitive elution with excess PIN2K

  • Implement negative selection steps with related protease inhibitors

  • Validate improved variants through binding kinetics analysis (KD potentially reaching 10⁻¹⁰-10⁻¹¹ M)

Single B Cell Approach:
For rapid antibody discovery:

  • Immunize mice with properly folded PIN2K

  • Isolate antigen-specific B cells using fluorescently labeled PIN2K

  • Perform single-cell RT-PCR to recover antibody genes

  • Express and screen recombinant antibodies

How can I assess the binding kinetics and affinity of antibodies targeting PIN2K?

Comprehensive characterization of antibody-PIN2K interactions requires multiple complementary approaches:

Surface Plasmon Resonance (SPR):

  • Immobilize either antibody or PIN2K on sensor chips

  • Measure association (kon) and dissociation (koff) rates

  • Calculate affinity constant (KD = koff/kon)

  • Compare binding under various buffer conditions to assess stability

Bio-Layer Interferometry (BLI):
Provides real-time, label-free analysis of binding kinetics with these advantages:

  • Requires smaller sample volumes than SPR

  • Allows higher throughput screening

  • Enables assessment of antibody binding to immobilized PIN2K in various conformational states

Isothermal Titration Calorimetry (ITC):
Measures thermodynamic parameters including:

  • Binding enthalpy (ΔH)

  • Entropy changes (ΔS)

  • Gibbs free energy (ΔG)

  • Stoichiometry of interaction

For advanced studies, computational modeling can complement experimental data by predicting antibody-PIN2K interactions at atomic resolution, similar to approaches used for other antibody-antigen complexes .

What epitope mapping techniques are most effective for PIN2K antibodies?

Effective epitope mapping strategies for PIN2K antibodies include:

X-ray Crystallography:
Provides atomic-level resolution of antibody-PIN2K complexes, revealing:

  • Precise amino acid contacts

  • Structural rearrangements upon binding

  • Water-mediated hydrogen bonding networks

Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):

  • Subject free PIN2K and antibody-bound PIN2K to deuterium exchange

  • Analyze protection patterns to identify binding regions

  • Model structural dynamics of interaction

Peptide Arrays:

  • Synthesize overlapping peptides covering PIN2K sequence

  • Probe with antibodies to identify linear epitopes

  • Create alanine-scanning arrays to identify critical residues

Cross-linking Mass Spectrometry:
Identify proximity relationships between antibody and PIN2K residues:

  • Use bifunctional cross-linkers with different spacer lengths

  • Digest complexes and analyze by LC-MS/MS

  • Identify cross-linked peptides to map interacting regions

Recent advances in cryo-electron microscopy have enabled visualization of antibody binding modes, as demonstrated with SARS-CoV-2 antibodies, providing insights into how antibodies can form specific binding pockets for their targets .

How can computational modeling enhance PIN2K antibody design and optimization?

Advanced computational approaches can significantly enhance PIN2K antibody design:

Machine Learning-Based Prediction:
Recent studies demonstrate how biophysically informed models can:

  • Predict antibody specificity profiles

  • Design antibodies that discriminate between related targets

  • Generate novel antibody sequences with customized binding properties

Molecular Dynamics Simulations:

  • Model antibody-PIN2K complexes in solution

  • Identify stable conformational states

  • Predict effects of mutations on binding energetics

  • Simulate water and ion distributions at binding interfaces

Deep Mutational Scanning Analysis:
Integration of experimental data with computational models allows:

  • Identification of mutation-tolerant regions

  • Prediction of specificity-enhancing mutations

  • Design of antibodies with improved stability and reduced immunogenicity

As demonstrated in recent antibody engineering studies, combining experimental selection data with biophysical modeling enables design of antibodies with customized specificity profiles beyond what can be achieved through selection alone .

What strategies address stability challenges in high-concentration PIN2K antibody formulations?

Developing stable high-concentration PIN2K antibody formulations requires addressing several key challenges:

Physical Stability Optimization:
To minimize aggregation and maintain stability:

  • Screen buffer conditions systematically (pH 5.0-6.5 often optimal)

  • Evaluate stabilizing excipients (sugars, amino acids, surfactants)

  • Implement accelerated stability studies with multiple analytical methods

Excipient ClassExampleTypical ConcentrationStabilization Mechanism
Amino acidsArginine50-200 mMSuppresses protein-protein interactions
SugarsTrehalose5-10% w/vPreferential hydration
SurfactantsPolysorbate 200.01-0.05% w/vInterfacial protection
PolyolsSorbitol5-10% w/vPreferential exclusion

Viscosity Reduction Approaches:
For high-concentration formulations (>100 mg/mL):

  • Add viscosity-reducing excipients (e.g., arginine, histidine)

  • Optimize solution ionic strength

  • Consider protein engineering to reduce self-association

  • Evaluate alternative formulation approaches (e.g., lyophilization)

Analytical Characterization:
Monitor antibody stability using orthogonal techniques:

  • Size-exclusion chromatography

  • Dynamic light scattering

  • Differential scanning calorimetry

  • Intrinsic/extrinsic fluorescence

  • Tandem-trapped ion mobility spectrometry (Tandem-TIMS)

How can PIN2K antibodies be engineered for enhanced specificity and cross-reactivity?

Engineering PIN2K antibodies with precise specificity profiles requires sophisticated approaches:

CDR Engineering Strategies:

  • Structure-guided mutagenesis of CDR loops

  • Grafting of specificity-determining residues

  • Lengthening or shortening CDR loops to modulate binding geometry

  • Incorporating non-canonical amino acids for enhanced binding properties

Frameworks for Cross-Reactivity Engineering:
Recent studies demonstrate how binding modes can be engineered to recognize:

  • Conserved epitopes for broad reactivity

  • Specific epitopes for selective binding

  • Multiple distinct epitopes simultaneously

Biophysical Model-Guided Engineering:
Advanced modeling approaches can:

  • Disentangle binding contributions from multiple epitopes

  • Identify residues contributing to cross-reactivity

  • Predict mutations that enhance selectivity

  • Design antibodies with customized specificity profiles

Research with coronavirus antibodies shows how engineering antibodies to target conserved regions with one binding domain while using another domain to target variable regions can create broadly neutralizing antibodies with exceptional specificity .

What are the methodological considerations for using PIN2K antibodies in structural biology?

Effective use of PIN2K antibodies in structural biology research requires specialized approaches:

Cryo-EM Sample Preparation:

  • Optimize antibody:PIN2K ratios to ensure complex formation

  • Screen buffer conditions to minimize preferred orientations

  • Consider Fab fragments to reduce complex size and flexibility

  • Implement GraFix method for stabilizing multi-component complexes

X-ray Crystallography Strategies:

  • Use antibodies as crystallization chaperones to facilitate PIN2K crystallization

  • Screen various antibody formats (IgG, Fab, scFv) for optimal crystal packing

  • Employ surface entropy reduction mutations to enhance crystallizability

  • Implement micro/macro seeding techniques to improve crystal quality

Advanced Imaging Applications:
Recent innovations in antibody structural characterization include:

  • Tandem-trapped ion mobility spectrometry (Tandem-TIMS)

  • Preserves native protein conformations during analysis

  • Allows study of dynamic protein modifications

  • Enables detailed study of antibody structure-function relationships

How can PIN2K antibodies be utilized in studying protease regulation in biological systems?

PIN2K antibodies provide powerful tools for investigating protease regulation:

Protease Activity Visualization:

  • Use fluorescently labeled PIN2K antibodies to track inhibitor localization

  • Develop proximity-based reporters to monitor PIN2K-protease interactions

  • Implement FRET-based systems to detect conformational changes upon binding

Functional Studies Methodology:

  • Deploy PIN2K antibodies as selective blocking agents

  • Use antibodies to discriminate between free and protease-bound PIN2K

  • Develop antibody-based sensors for real-time monitoring of proteolytic activity

Cellular Localization Studies:
Antibodies enable precise tracking of PIN2K distribution:

  • Super-resolution microscopy techniques for nanoscale localization

  • Live-cell imaging to monitor dynamics of inhibitor-protease interactions

  • Correlative light and electron microscopy for ultrastructural context

These approaches parallel methodologies used with other antibody systems, such as those developed for studying viral protein interactions .

What novel antibody engineering approaches are applicable to PIN2K research?

Cutting-edge antibody engineering technologies offer new possibilities for PIN2K research:

Bispecific Antibody Platforms:
Design antibodies that simultaneously:

  • Bind PIN2K with one arm

  • Target related proteases or cofactors with the second arm

  • Create novel functionalities through forced proximity

Intracellular Antibody Development:

  • Engineer cell-penetrating antibodies to access intracellular PIN2K

  • Develop antibody fragments stable in reducing cytoplasmic environments

  • Create genetic constructs for intracellular antibody expression

Engineered Binding Proteins Beyond Traditional Antibodies:
Alternative scaffolds with potential applications in PIN2K research:

  • DARPins (Designed Ankyrin Repeat Proteins)

  • Affibodies

  • Monobodies

Recent advances in antibody development platforms include single B cell sorting techniques that enable rapid isolation of antigen-specific antibodies, potentially accelerating PIN2K antibody discovery .

How can systems biology approaches incorporate PIN2K antibody data to understand protease networks?

Integrating PIN2K antibody data into systems biology frameworks provides comprehensive insights:

Multi-Omic Data Integration:

  • Combine antibody-based proteomic data with transcriptomics

  • Correlate PIN2K-protease interactions with cellular phenotypes

  • Map regulatory networks controlling protease inhibitor expression

Quantitative Interaction Mapping:

  • Determine stoichiometric ratios of PIN2K-protease complexes

  • Measure binding affinities across different cellular compartments

  • Assess competition between multiple proteases for limited inhibitor

Mathematical Modeling Approaches:
Develop computational models incorporating:

  • Antibody-derived interaction parameters

  • Spatial and temporal dynamics of PIN2K activity

  • Feedback mechanisms regulating protease activity

These integrative approaches parallel methods used to understand complex biological systems, such as immune responses to pathogens, where antibody interactions play critical roles .

What are the latest developments in humanizing antibodies that could benefit PIN2K research?

Recent advances in antibody humanization offer significant benefits for PIN2K research:

Computational Humanization Platforms:
Modern approaches include:

  • Structure-guided CDR grafting with minimal framework changes

  • Homology-based framework selection to minimize immunogenicity

  • Machine learning algorithms to predict optimal humanized sequences

  • In silico affinity maturation to restore binding properties

Humanization Success Metrics:
Key parameters to evaluate in humanized PIN2K antibodies:

  • Retention of binding affinity (target <3-fold reduction)

  • Thermal stability (comparable to parent antibody)

  • Expression yields in mammalian systems

  • Aggregation propensity under physiological conditions

Emerging Direct Human Antibody Discovery:
Human antibody technologies eliminating the need for humanization:

  • Human naïve phage display libraries with >7×10¹⁰ diversity

  • Single B cell isolation from human donors

  • Transgenic animals expressing human antibody repertoires

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.